Everest Organics Ltd

Everest Organics Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 05 Aug 2025. However, the analysis and financial metrics discussed below reflect the stock's current position as of 25 January 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Everest Organics Ltd is rated 'Hold' by MarketsMOJO, a rating that was last updated on 05 Aug 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 14 January 2026, providing investors with an up-to-date perspective on the stock’s fundamentals, valuation, financial trends, and technical outlook.

Everest Organics Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 05 Aug 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 03 January 2026, providing investors with the latest insights into its performance and outlook.

Everest Organics Ltd, a key player in the Pharmaceuticals & Biotechnology sector, reached a significant milestone today by hitting a new 52-week high of Rs.536.4. This marks a remarkable surge in the stock price, reflecting strong momentum and sustained investor confidence over the past year.

Everest Organics Ltd, a key player in the Pharmaceuticals & Biotechnology sector, reached a new all-time high of Rs.536.4 on 2 Jan 2026, underscoring its robust market performance and sustained investor confidence.

Everest Organics Ltd, a key player in the Pharmaceuticals & Biotechnology sector, reached a significant milestone on 30 Dec 2025 by hitting a new 52-week and all-time high of Rs.513.8. This marks a remarkable rally for the stock, reflecting strong momentum over the past year.

Everest Organics Ltd, a key player in the Pharmaceuticals & Biotechnology sector, reached a new all-time high of Rs.513.8 on 30 Dec 2025, underscoring its robust performance and sustained growth trajectory in a competitive market environment.

Everest Organics Ltd surged to a fresh 52-week and all-time high of Rs.503.9 on 29 Dec 2025, marking a significant milestone in the company’s stock performance. The pharmaceutical and biotechnology firm demonstrated robust momentum, outperforming its sector and showcasing strong price strength amid a volatile trading session.

Everest Organics Ltd, a key player in the Pharmaceuticals & Biotechnology sector, has reached a significant milestone by hitting an all-time high in its stock price. This achievement reflects the company’s sustained strong performance and resilience in a competitive market environment.

Everest Organics has experienced a revision in its market evaluation, reflecting shifts in its financial and technical outlook. The pharmaceutical and biotechnology microcap has demonstrated notable stock returns alongside a complex financial profile, prompting a reassessment of its investment appeal.

Everest Organics, a key player in the Pharmaceuticals & Biotechnology sector, has reached a significant milestone by touching a new 52-week high of Rs.499. This achievement marks a notable phase in the stock’s performance, reflecting sustained momentum over recent trading sessions.

Everest Organics, a key player in the Pharmaceuticals & Biotechnology sector, reached a new all-time high of Rs.499 today, marking a significant milestone in its market journey. The stock’s performance over recent periods highlights a robust trajectory that has outpaced broader market indices and sector benchmarks.

Everest Organics has reached a new 52-week high, touching Rs.490 today, reflecting a notable surge in its stock price and marking a key milestone for the Pharmaceuticals & Biotechnology company. This achievement underscores the stock’s strong momentum amid a volatile trading session.

Everest Organics, a key player in the Pharmaceuticals & Biotechnology sector, reached a new all-time high of Rs.490 today, reflecting a notable phase in its market journey. This milestone underscores the company’s sustained performance amid a volatile trading session and highlights its position relative to broader market indices.

Everest Organics, a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting a nuanced shift in its financial and technical outlook. This change comes amid a backdrop of mixed fundamental indicators and notable stock performance over the past year.